Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adamas, Bellerophon, Bridge, Byondis, Cure, Deinove, Essa, Evofem, Moderna, Nicox, QED, Ribomic, Valbiotis, Vivoryon.